184 related articles for article (PubMed ID: 11151749)
1. Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia.
Raaska K; Neuvonen PJ
Eur J Clin Pharmacol; 2000 Nov; 56(8):585-9. PubMed ID: 11151749
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole.
Raaska K; Neuvonen PJ
Eur J Clin Pharmacol; 1998 Apr; 54(2):167-70. PubMed ID: 9626923
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.
Smith RL; Haslemo T; Andreassen OA; Eliasson E; Dahl ML; Spigset O; Molden E
CNS Drugs; 2017 Nov; 31(11):991-997. PubMed ID: 28948574
[TBL] [Abstract][Full Text] [Related]
4. Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia.
Raaska K; Raitasuo V; Neuvonen PJ
Eur J Clin Pharmacol; 2001 Dec; 57(10):705-8. PubMed ID: 11829199
[TBL] [Abstract][Full Text] [Related]
5. Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients.
Raaska K; Raitasuo V; Laitila J; Neuvonen PJ
Basic Clin Pharmacol Toxicol; 2004 Jan; 94(1):13-8. PubMed ID: 14725610
[TBL] [Abstract][Full Text] [Related]
6. Another use of silica gel and aqueous eluent for HPLC analysis of clozapine and desmethylclozapine.
Coudoré F; Nicolay A; Hoareau M; Eschalier A
J Anal Toxicol; 1999; 23(3):195-9. PubMed ID: 10369329
[TBL] [Abstract][Full Text] [Related]
7. Effect of fluvoxamine augmentation and smoking on clozapine serum concentrations.
Augustin M; Schoretsanitis G; Pfeifer P; Gründer G; Liebe C; Paulzen M
Schizophr Res; 2019 Aug; 210():143-148. PubMed ID: 31182321
[TBL] [Abstract][Full Text] [Related]
8. Bacterial pneumonia can increase serum concentration of clozapine.
Raaska K; Raitasuo V; Arstila M; Neuvonen PJ
Eur J Clin Pharmacol; 2002 Aug; 58(5):321-2. PubMed ID: 12185555
[TBL] [Abstract][Full Text] [Related]
9. Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia.
Islam F; Maciukiewicz M; Freeman N; Huang E; Tiwari A; Mulsant BH; Pollock BG; Remington G; Kennedy JL; Müller DJ; Rajji TK
J Psychopharmacol; 2021 Jan; 35(1):31-39. PubMed ID: 33143542
[TBL] [Abstract][Full Text] [Related]
10. Whole saliva and plasma levels of clozapine and desmethylclozapine.
Dumortier G; Lochu A; Zerrouk A; Van Nieuwenhuyse V; Colen de Melo P; Roche Rabreau D; Degrassat K
J Clin Pharm Ther; 1998 Feb; 23(1):35-40. PubMed ID: 9756110
[TBL] [Abstract][Full Text] [Related]
11. Lack of CYP3A4 inhibition by grapefruit juice and ketoconazole upon clozapine administration in vivo.
Lane HY; Chiu CC; Kazmi Y; Desai H; Lam YW; Jann MW; Chang WH
Drug Metabol Drug Interact; 2001; 18(3-4):263-78. PubMed ID: 11791889
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
Wetzel H; Anghelescu I; Szegedi A; Wiesner J; Weigmann H; Härter S; Hiemke C
J Clin Psychopharmacol; 1998 Feb; 18(1):2-9. PubMed ID: 9472836
[TBL] [Abstract][Full Text] [Related]
13. Effect of treatment duration on plasma levels of clozapine and N-desmethylclozapine in men and women.
Fabrazzo M; Esposito G; Fusco R; Maj M
Psychopharmacology (Berl); 1996 Mar; 124(1-2):197-200. PubMed ID: 8935816
[TBL] [Abstract][Full Text] [Related]
14. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
[TBL] [Abstract][Full Text] [Related]
15. Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms.
Akamine Y; Sugawara-Kikuchi Y; Uno T; Shimizu T; Miura M
Ann Clin Biochem; 2017 Nov; 54(6):677-685. PubMed ID: 27932669
[TBL] [Abstract][Full Text] [Related]
16. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia.
Guitton C; Abbar M; Kinowski JM; Chabrand P; Bressolle F
J Clin Psychopharmacol; 1998 Dec; 18(6):470-6. PubMed ID: 9864080
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic-resistant schizophrenic patients treated by clozapine: clinical evolution, plasma and red blood cell clozapine and desmethylclozapine levels.
Aymard N; Baldacci C; Leyris A; Smagghe PO; Tribolet S; Vacheron MN; Viala A; Caroli F
Therapie; 1997; 52(3):227-32. PubMed ID: 9366107
[TBL] [Abstract][Full Text] [Related]
18. Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients.
Molins C; Carceller-Sindreu M; Navarro H; Carmona C; Piñeiro M; Martínez E; Álvarez E; Portella MJ
Psychiatry Res; 2017 Dec; 258():153-157. PubMed ID: 29024893
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients.
Liu HC; Chang WH; Wei FC; Lin SK; Lin SK; Jann MW
Ther Drug Monit; 1996 Apr; 18(2):200-7. PubMed ID: 8721285
[TBL] [Abstract][Full Text] [Related]
20. Clozapine and desmethylclozapine: correlation with neutrophils and leucocytes counting in Mexican patients with schizophrenia.
Vaquero-Baez M; Díaz-Ruíz A; Tristán-López L; Aviña-Cervantes C; Torner C; Ramírez-Bermúdez J; Montes S; Ríos C
BMC Psychiatry; 2019 Oct; 19(1):295. PubMed ID: 31597566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
